1. Home
  2. AUID vs INTS Comparison

AUID vs INTS Comparison

Compare AUID & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.69

Market Cap

26.8M

Sector

Technology

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.37

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
INTS
Founded
2009
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.8M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AUID
INTS
Price
$1.69
$0.37
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$2.25
AVG Volume (30 Days)
16.9M
1.1M
Earning Date
03-12-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,834,458.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
141.81
N/A
52 Week Low
$0.84
$0.19
52 Week High
$9.58
$2.52

Technical Indicators

Market Signals
Indicator
AUID
INTS
Relative Strength Index (RSI) 55.40 46.47
Support Level $1.67 $0.34
Resistance Level $1.88 $0.39
Average True Range (ATR) 0.18 0.02
MACD 0.01 0.00
Stochastic Oscillator 48.27 46.34

Price Performance

Historical Comparison
AUID
INTS

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: